Integrating lymphovascular and perineural invasion into TNM staging: a novel ITNM system for enhanced prognostic stratification in colorectal cancer.
[BACKGROUND] The standard TNM staging system for colorectal cancer (CRC) fails to reflect true tumor biology because it ignores key histopathologic features such as lymphovascular and perineural invas
- 표본수 (n) 185
- p-value p = 0.018
- p-value p = 0.025
- 95% CI 0.691-0.776
- HR 2.10
APA
Hu J, Zhang M, et al. (2026). Integrating lymphovascular and perineural invasion into TNM staging: a novel ITNM system for enhanced prognostic stratification in colorectal cancer.. Frontiers in oncology, 16, 1745324. https://doi.org/10.3389/fonc.2026.1745324
MLA
Hu J, et al.. "Integrating lymphovascular and perineural invasion into TNM staging: a novel ITNM system for enhanced prognostic stratification in colorectal cancer.." Frontiers in oncology, vol. 16, 2026, pp. 1745324.
PMID
41684596
Abstract
[BACKGROUND] The standard TNM staging system for colorectal cancer (CRC) fails to reflect true tumor biology because it ignores key histopathologic features such as lymphovascular and perineural invasion. We therefore developed and validated an "ITNM" classification that folds these two factors into the N stage, yielding more accurate prognoses and greater clinical value.
[METHODS] A retrospective cohort of 442 stage I-III CRC patients underwent radical resection (2015-2021). Propensity score matching (PSM) created balanced exposure (LVI/PNI-positive, n = 185) and control (LVI/PNI-negative, n = 257) groups. The ITNM system was constructed by upstaging the N category based on LVI/PNI status. Predictive performance was evaluated using C-index, ROC-AUC, calibration curves, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
[RESULTS] Multivariate analysis confirmed LVI (HR = 2.10, p = 0.018) and PNI (HR = 2.28, p = 0.025) as independent predictors of overall survival (OS). The LVI/PNI-positive group had significantly lower 5-year OS (69.5% . 88.2%, p < 0.001). The ITNM system demonstrated superior discriminative ability for 5-year OS (C-index = 0.715; AUC = 0.735, 95% CI: 0.691-0.776), excellent calibration (p = 0.489), and higher net benefit on DCA. Significant reclassification improvement was confirmed (NRI = 0.306, < 0.001; IDI = 0.061, < 0.001).
[CONCLUSION] The ITNM system significantly enhances prognostic accuracy by integrating LVI and PNI into TNM staging, enabling risk-adapted therapeutic decision-making and representing a paradigm shift in CRC stratification.
[METHODS] A retrospective cohort of 442 stage I-III CRC patients underwent radical resection (2015-2021). Propensity score matching (PSM) created balanced exposure (LVI/PNI-positive, n = 185) and control (LVI/PNI-negative, n = 257) groups. The ITNM system was constructed by upstaging the N category based on LVI/PNI status. Predictive performance was evaluated using C-index, ROC-AUC, calibration curves, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
[RESULTS] Multivariate analysis confirmed LVI (HR = 2.10, p = 0.018) and PNI (HR = 2.28, p = 0.025) as independent predictors of overall survival (OS). The LVI/PNI-positive group had significantly lower 5-year OS (69.5% . 88.2%, p < 0.001). The ITNM system demonstrated superior discriminative ability for 5-year OS (C-index = 0.715; AUC = 0.735, 95% CI: 0.691-0.776), excellent calibration (p = 0.489), and higher net benefit on DCA. Significant reclassification improvement was confirmed (NRI = 0.306, < 0.001; IDI = 0.061, < 0.001).
[CONCLUSION] The ITNM system significantly enhances prognostic accuracy by integrating LVI and PNI into TNM staging, enabling risk-adapted therapeutic decision-making and representing a paradigm shift in CRC stratification.
같은 제1저자의 인용 많은 논문 (5)
- EZR-ROS1 rearrangement as a novel mechanism of acquired resistance to EGFR-TKIs in NSCLC: a case report and literature review.
- Epidemiological trends and characteristics of oral tongue cancer in females: systematic review and meta-analysis.
- Dual targeting of BRAF and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress.
- Targeting ICMT: A promising strategy in cancer treatment (Review).
- Update on the clinical features, treatment and histogenesis of combined hepatocellular-cholangiocarcinoma.